ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO364

Automated Blood Pressure Monitoring Patterns in Peritoneal Dialysis Modalities: Report from a Nephrology Reference Center in Mexico

Session Information

Category: Hypertension and CVD

  • 1602 Hypertension and CVD: Clinical

Authors

  • Quintero Solis, Rodrigo, Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
  • Vega Cardona, Javier Alejandro, Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
  • Mendoza Villalobos, Edna Teresa, Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
  • Ruiz Gonzalez, Mario A., Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
  • De La Torre Alvarez, Felipe De Jesus, Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
  • González Franco, Mireya, Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
  • Cedillo, Michelle Marisol, Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
  • Nava-Vargas, Miriam Gabriela, Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
  • Anaya, Juan Carlos, Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
  • Robles Garcia, Francisco, Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
  • Franco Barrera, Miguel Angel, Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
  • Breien Alcaraz, Hugo Sergio, Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
  • Torres, Sidney, Hospital Regional ISSSTE Valentin Gomez Farias, Zapopan, Jalisco, Mexico
Background

Arterial hypertension is a condition that affects most patients with chronic kidney disease and is a modifiable parameter to improve cardiovascular outcomes. Automated Blood Pressure Monitoring is considered the gold standard for surveillance. Various methods of BP measurement have been compared, including office-based measurements and self-monitoring. An analysis by Vaios demonstrated correlation between those compared to ABPM. ABPM classifies BP patterns over 24 hours, specifically during the night when it physiologically decreases, termed as Dipper. If this does not occur, it is considered non-dipper, a condition where BP figures increase, classified as Reverse Dipper, which increases CV risk. There are few studies that relates BP patterns to Renal Replacement Therapy. In a study of 38 patients, failed to demonstrate that the modality of Peritoneal Dialysis modifies BP patterns.

Methods

This is a retrospective, single-center study from 2014 to 2019, involving 150 patients who underwent ABPM for the first time. 64% were male, with a mean age of 49 years. 66% were on APD and 34% on CAPD. 42% were using diuretics, 73% iRAS, 41% calcium channel blockers, 28% a-blockers, and 21% b-blockers.

Results

The study found mean BP of 104 +/- 16 mmHg, daytime mean 105 +/- 16 mmHg, and nighttime mean 102 +/- 19 mmHg. In CAPD, 14% showed Dipper pattern, 36% reverse Dipper; in APD, 21% Dipper, 19% reverse Dipper. Non-parametric distribution confirmed via KS test (p<0.001). Significant difference in Dipper distributions by dialysis therapy (Mann-Whitney U test: U=2061.000, Z=-2.005, p=0.045). Significant relationship shown via Pearson's χ2 (χ2=5.023, df=3, p=0.170) and linear-by-linear association (χ2=4.260, df=1, p=0.039). Negative correlation observed through Kendall's Tau-b (τ=-0.155, p=0.045) and Spearman's Rho (ρ=-0.164, p=0.045). CAPD had more reverse Dipper compared to APD.

Conclusion

Patients managed with CAPD had a statistically significant higher incidence of reverse Dipper pattern compared to those managed with APD.